Confirma is showing at the RSNA meeting its breast MR coil enhanced with interventional components. Launched at RSNA 2006 as a purely diagnostic device, the Access Breast Coil is now outfitted with a grid plate and stabilization plate, a configuration cleared in July by the FDA. The four-channel phased-array coil was also modified to improve patient comfort, reduce weight, and increase physician access to the patient. The version slated for the RSNA exhibit floor is certified for use on Siemens Avanto, Espree, and Symphony MR scanners.
Confirma is showing at the RSNA meeting its breast MR coil enhanced with interventional components. Launched at RSNA 2006 as a purely diagnostic device, the Access Breast Coil is now outfitted with a grid plate and stabilization plate, a configuration cleared in July by the FDA. The four-channel phased-array coil was also modified to improve patient comfort, reduce weight, and increase physician access to the patient. The version slated for the RSNA exhibit floor is certified for use on Siemens Avanto, Espree, and Symphony MR scanners.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.